한글목차

세계의 결핵 진단 시장은 2018년에 17억 4,840만 달러로 평가되며, 2023년까지 CAGR 3.0% 이상으로 성장했습니다.

핵산 검사의 채택 증가

핵산 검사의 채택이 증가하면서 결핵 진단 시장의 성장을 지원했습니다. 결핵 핵산 증폭 검사(NAAT)는 객담 및 기타 호흡기 검체에서 결핵균 복합체(MTBC) DNA(데옥시리보핵산)를 확인하는 데 사용됩니다. 핵산 검사는 기존 현미경 검사보다 정확도가 높고 결과가 더 빠르다는 장점이 있습니다. 예를 들어 2022년 로드아일랜드 보건국이 발표한 데이터에 따르면 로드아일랜드 보건연구소(RISHL)는 호흡기 검체에서 결핵균 복합체(MTB-complex) DNA의 존재를 검출하는 데 사용되는 자동 분자진단 테스트인 NAAT에 세파이드 엑스퍼트(Sephide Xpert) MTB/RIF assay를 사용하고 있는 것으로 확인되었습니다. 또한 2021년 2월, 세계보건기구(WHO)는 결핵 및 약제 내성 진단을 위한 새로운 분자 분석에 대한 최신 정보를 발표했습니다. 새로운 기술 업데이트에는 결핵과 리팜피신 및 이소니아지드에 대한 내성을 검출하기 위한 중등도 복잡도의 자동 핵산 증폭 검사(NAAT), 이소니아지드와 2차 항결핵제에 대한 내성을 검출하기 위한 낮은 복잡도의 자동 NAAT, 피라지나미드에 대한 내성을 검출하기 위한 복잡도가 높은 높은 혼성화 기반 NAAT가 포함되었습니다. 따라서 핵산 검사의 채택 증가는 결핵 진단 시장의 성장을 지원했습니다.

목차

제1장 개요

• 결핵 진단 - 시장의 매력과 거시경제 상황

제2장 목차

제3장 표 리스트

제4장 도표 리스트

제5장 리포트 구성

제6장 시장의 특징

• 일반 시장 정의
• 개요
• 결핵 진단 시장 정의와 세분화
• 시장 세분화 : 검사 유형별
  • 방사선 검사
  • 핵산 검사
  • 사이토카인 검출 검사
  • 약제 내성 검사
  • 피부 테스트/Mantoux Test(TST)
  • 혈액검사/혈청 검사
  • 도말 현미경검사
  • 배양 검사
  • 기타 검사 유형 유형
• 시장 세분화 : 병기별
  • 잠복 결핵
  • 활동성 결핵
• 시장 세분화 : 최종사용자별
  • 병원 및 진단 연구소
  • 의사 오피스 검사실
  • 표준실험실
  • 학술연구 시설

제7장 주요 시장 동향

• 결핵 진단을 위한 차세대 시퀀싱(NGS) 플랫폼
• 첨단 진단 솔루션을 위한 신제품 혁신
• 결핵 검출의 정도와 신뢰성을 향상시키는 T세포 검사의 서론
• 인공지능(AI) 기반 결핵 진단의 정도 향상
• 리소스가 한정된 환경에서의 액세스를 강화하기 위한 휴대용 디바이스의 사용
• 진단에 대한 액세스를 강화하기 위한 시장 기업 간의 전략적 제휴
• 결핵 검출의 상황을 일변시키는 기술의 진보
• 결핵의 저침습 검출을 위한 혈액검사의 서론

제8장 결핵 진단 시장 - 거시경제 시나리오

• COVID-19의 영향 : 결핵 진단 시장
• 우크라이나 전쟁의 영향 : 결핵 진단 시장
• 고인플레이션의 영향 : 결핵 진단 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 성장 촉진요인, 2018-2023
  • 시장 성장 억제요인, 2018-2023
• 시장 성장 예측, 2023-2028, 2033F
  • 시장 성장 촉진요인, 2023-2028
  • 시장 성장 억제요인, 2023-2028

제10장 세계의 결핵 진단 시장 : 세분화

• 세계의 결핵 진단 시장 : 검사 유형별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 결핵 진단 시장 : 병기별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 결핵 진단 시장 : 최종사용자별, 실적과 예측, 2018-2023, 2028F, 2033F

제11장 결핵 진단 시장 : 지역·국가별 분석

• 세계의 결핵 진단 시장 : 지역별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 결핵 진단 시장 : 국가별, 실적과 예측, 2018-2023, 2028F, 2033F

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• 기업 개요
• Becton, Dickinson and Company
• Qiagen N.V.
• F. Hoffman-La Roche Ltd
• BioMerieux SA
• Danaher Corporation(Cepheid, Inc.)

제20장 기타 대기업과 혁신적 기업

• Abbott Laboratories, Inc
• Bio-Rad Laboratories, Inc
• Thermo Fisher Scientific, Inc
• PerkinElmer, Inc
• Bio-Techne Corporation
• Hologic, Inc
• Laboratory Corporation
• Siemens Healthineers
• Akonni Biosystems Inc
• Hain Lifescience GmbH
• Creative Diagnostics
• Lionex GmbH
• Genedrive PLC
• Mylab Discovery Solutions Pvt. Ltd
• AdvaCare Pharma

제21장 경쟁 벤치마킹

제22장 경쟁 대시보드

제23장 주요 합병과 인수

• Molbio Diagnostics Acquired Prognosys Medical Systems
• SD Biosensor Acquired Relab
• Hologic Inc. Acquired Mobidiag Oy
• PerkinElmer Acquired Oxford Immunotec
• Thermo Fisher Scientific Acquired Mesa Biotech Inc.

제24장 기회와 전략

• 세계의 결핵 진단 시장, 2028 : 새로운 기회를 제공하는 국가
• 세계의 결핵 진단 시장, 2028 : 새로운 기회를 제공하는 부문
• 세계의 결핵 진단 시장, 2028 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제25장 결핵 진단 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제26장 부록

영문목차

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for tuberculosis (TB) diagnosis. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

TB is an infectious disease that primarily affects the lungs and is caused by the bacterium Mycobacterium tuberculosis. Imaging studies, sputum microscopy, culture and molecular testing are some of the tests and techniques used in TB diagnoses. The purpose of TB diagnostics is to promptly and precisely identify people who have active TB so that they can get the right care and avoid spreading it to others.

The global tuberculosis diagnostics market was valued at $1,748.4 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 3.0%

Rise In The Adoption Of Nucleic Acid Testing

During the historic period, the rise in the adoption of nucleic acid testing supported the growth of the tuberculosis diagnostics market. A nucleic acid amplification test (NAAT) for tuberculosis (TB) is used to identify Mycobacterium tuberculosis complex (MTBC) DNA (deoxyribonucleic acid) in sputum or other respiratory samples. The nucleic acid testing provides benefits such as greater accuracy than conventional microscopy techniques and faster findings. For example, in 2022, according to data published by the State of Rhode Island Department of Health, it has been observed that Rhode Island State Health Laboratory (RISHL) utilizes the Cepheid Xpert MTB/RIF assay for NAAT, an automated molecular diagnostic test that is used to detect the presence of Mycobacterium tuberculosis complex (MTB-complex) DNA in respiratory specimens. Further, in February 2021, the World Health Organization (WHO) announced updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance. The updates on new technologies included moderate complexity automated Nucleic Acid Amplification Tests (NAATs), for detection of TB and resistance to rifampicin and isoniazid, low complexity automated NAATs for detection of resistance to isoniazid and second-line anti-TB agents and high complexity hybridization-based NAATs for detection of resistance to pyrazinamide. Therefore, the rise in the adoption of nucleic acid testing supported the growth of the tuberculosis diagnostics market.

Next Generation Sequencing (NGS) Platforms For TB Diagnostics

The use of next-generation sequencing (NGS) platforms to detect drug-resistant strains of tuberculosis (TB) at a high throughput and with higher speed and accuracy is emerging as a potential trend in TB diagnostics. Companies operating in the tuberculosis diagnostics market are focusing on next generation sequencing platform for rapidly diagnosing drug-resistant tuberculosis. For example, in April 2024, QIAGEN, a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic research and pharmaceutical research, launched the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against tuberculosis (TB), the world's leading infectious disease killer. The QIAseq xHYB Mycobacterium tuberculosis Panel represents a major advancement in solving the problem of bacterial WGS from complex host samples, using next-generation sequencing (NGS). Further, in March 2023, Illumina, a US-based biotechnology company and GenoScreen, a France-based genomics company, introduced a new tuberculosis test that combines products from Illumina with the GenoScreen Deeplex Myc-TB assay, a targeted next-generation sequencing (NGS)-based test for Tuberculosis (TB). This test can detect TB mycobacteria, as well as more than 100 non-TB mycobacterial species.

The global tuberculosis diagnostics market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 28.3% of the total market in 2023.

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tuberculosis diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for tuberculosis diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tuberculosis diagnostics market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by test type, by disease stage and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tuberculosis diagnostics market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by test type, by disease stage and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for tuberculosis diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
• 2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
• 3) By End User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
• Companies Mentioned: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La Roche AG; bioMerieux SA.; Danaher Corporation (Cepheid, Inc.)
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tuberculosis diagnostics indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Tuberculosis Diagnostics - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Tuberculosis Diagnostics Market Definition And Segmentations
• 6.4 Market Segmentation By Test Type
  • 6.4.1 Radiographic Test
  • 6.4.2 Nucleic Acid Testing
  • 6.4.3 Cytokine Detection Test
  • 6.4.4 Drug Resistance Test
  • 6.4.5 Skin Test/Mantoux Test (TST)
  • 6.4.6 Blood Test/Serology Test
  • 6.4.7 Smear Microscopy
  • 6.4.8 Cultured-Based Tests
  • 6.4.9 Other Test Types
• 6.5 Market Segmentation By Disease Stage
  • 6.5.1 Latent Tuberculosis
  • 6.5.2 Active Tuberculosis
• 6.6 Market Segmentation By End-User
  • 6.6.1 Hospitals And Diagnostic Laboratories
  • 6.6.2 Physician's Office Laboratories
  • 6.6.3 Reference Laboratories
  • 6.6.4 Academics And Research Facilities

7 Major Market Trends

• 7.1 Next Generation Sequencing (NGS) Platforms For TB Diagnostics
• 7.2 New Product Innovations For Advanced Diagnostics Solutions
• 7.3 Introduction Of T Cell Tests To Transform TB Detection With Precision And Reliability
• 7.4 Artificial Intelligence (AI)-Based Tuberculosis Diagnostics To Enhance Accuracy
• 7.5 Use Of Portable Devices To Enhance Access In Resource-Limited Settings
• 7.6 Strategic Collaborations Among Market Players To Enhance Access To Diagnostics
• 7.7 Technology Advancements To Transform The Landscape Of TB Detection
• 7.8 Introduction Of Blood-Based Tests For Minimally Invasive Detection Of TB

8 Tuberculosis Diagnostics Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The Tuberculosis Diagnostics Market
• 8.2 Impact Of The War In Ukraine On The Tuberculosis Diagnostics Market
• 8.3 Impact Of High Inflation On The Tuberculosis Diagnostics Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Tuberculosis Diagnostics Market Segmentation

• 10.1 Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Tuberculosis Diagnostics Market, Regional and Country Analysis

• 11.1 Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Tuberculosis Diagnostics Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Tuberculosis Diagnostics Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Tuberculosis Diagnostics Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Tuberculosis Diagnostics Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Becton, Dickinson and Company
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Qiagen N.V.
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 F. Hoffman-La Roche Ltd
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 BioMerieux SA
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Danaher Corporation (Cepheid, Inc.)
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Tuberculosis Diagnostics Market Other Major And Innovative Companies

• 20.1 Abbott Laboratories, Inc
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Bio-Rad Laboratories, Inc
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 Thermo Fisher Scientific, Inc
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 PerkinElmer, Inc
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Bio-Techne Corporation
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 Hologic, Inc
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 Laboratory Corporation
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 Siemens Healthineers
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 Akonni Biosystems Inc
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 Hain Lifescience GmbH
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 Creative Diagnostics
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Lionex GmbH
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 Genedrive PLC
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Mylab Discovery Solutions Pvt. Ltd
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 AdvaCare Pharma
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Molbio Diagnostics Acquired Prognosys Medical Systems
• 23.2 SD Biosensor Acquired Relab
• 23.3 Hologic Inc. Acquired Mobidiag Oy
• 23.4 PerkinElmer Acquired Oxford Immunotec
• 23.5 Thermo Fisher Scientific Acquired Mesa Biotech Inc.

24 Opportunities And Strategies

• 24.1 Global Tuberculosis Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global Tuberculosis Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global Tuberculosis Diagnostics Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Tuberculosis Diagnostics Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer